Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Prestige Consumer Healthcare ( (PBH) ) has shared an update.
Prestige Consumer Healthcare reported its financial results for the third quarter and nine months ended December 31, 2024, showcasing a revenue increase of 2.7% to $290.3 million and a 15% rise in diluted earnings per share to $1.22, driven by strong international performance and improved Clear Eyes sales. The company also reduced its leverage to 2.5x, repurchased shares, and raised its full-year earnings outlook, highlighting its robust free cash flow and strategic capital allocation to enhance shareholder value.
More about Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc. operates within the consumer healthcare industry, specializing in over-the-counter (OTC) healthcare products. The company focuses on both North American and International markets, offering products in categories such as gastrointestinal, dermatologicals, and women’s health, with known brands like Clear Eyes and Hydralyte.
YTD Price Performance: -2.08%
Average Trading Volume: 282,282
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.76B
See more insights into PBH stock on TipRanks’ Stock Analysis page.
